Phloridzin reduces blood glucose levels and improves lipids metabolism in streptozotocin-induced diabetic rats

Molecular Biology Reports

Volumn 39, Issue 5, 2012, Pages 5299-5306

  Najafian, Mahmood ^a   Jahromi, Mohammad Zareain ^a   Nowroznejhad, Mohammad Javad ^a   Khajeaian, Parastoo ^a   Kargar, Mohammad Mehdi ^a   Sadeghi, Mehdi ^a   Arasteh, Amir ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Diabetes; Hyperglycemia; Hyperlipidemia; Phloridzin; Sodium glucose cotransporters (SGLT1) (SGLT2)

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHLORIZIN; STREPTOZOCIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DYSLIPIDEMIA; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LIPID METABOLISM; MALE; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL; URINE VOLUME; WEIGHT REDUCTION; ANIMAL; BLOOD; BODY WEIGHT; DRINKING BEHAVIOR; EXPERIMENTAL DIABETES MELLITUS; FEEDING BEHAVIOR; URINE; WISTAR RAT;

MALUS X DOMESTICA; RATTUS;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DRINKING BEHAVIOR; FEEDING BEHAVIOR; INSULIN; LIPID METABOLISM; LIPIDS; MALE; PHLORHIZIN; RATS; RATS, WISTAR;

EID: 84863738927     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1328-7     Document Type: Article

References (41)

1. Song Y, Manson JE, Buring JE, Sesso HD, Liu S (2005) Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: a prospective study and cross-sectional analysis. J Am Coll Nutr 24:376-384
2. Arts IC, Hollman PC (2005) Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 81(Suppl 1):317S-325S
3. Knekt P, Jarvinen R, Reunanen A, Maatela J (1996) Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ 312:478-481
4. Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A (2002) Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76:560-568
5. Russo GL (2007) Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem Pharmacol 74:533-544
6. Woods RK, Walters EH, Raven JM, Wolfe R, Ireland PD, Thien FC, Abramson MJ (2003) Food and nutrient intakes and asthma risk in young adults. Am J Clin Nutr 78:414-421
7. Linseisen J, Rohrmann S, Miller AB, Bueno-de-Mesquita HB, Buchner FL, Vineis P, Agudo A, Gram IT, Janson L, Krogh V, Overvad K, Rasmuson T, Schulz M, Pischon T, Kaaks R, Nieters A, Allen NE, Key TJ, Bingham S, Khaw KT, Amiano P, Barricarte A, Martinez C, Navarro C, Quiros R, Clavel-Chapelon F, Boutron-Ruault MC, Touvier M, Peeters PH, Berglund G, Hallmans G, Lund E, Palli D, Panico S, Tumino R, Tjonneland A, Olsen A, Trichopoulou A, Trichopoulos D, Autier P, Boffetta P, Slimani N, Riboli E (2007) Fruit and vegetable consumption and lung cancer risk: updated information from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 121:1103-1114
8. Boyer J, Liu RH (2004) Apple phytochemicals and their health benefits. Nutr J 3:5
9. Mennen LI, Sapinho D, Ito H, Bertrais S, Galan P, Hercberg S, Scalbert A (2006) Urinary flavonoids and phenolic acids as biomarkers on intake for polyphenol-rich foods. Br J Nutr 96: 191-198
10. Bellion P, Hofmann T, Pool-Zobel BL, Will F, Dietrich H, Knaup B, Richling E, Baum M, Eisenbrand G, Janzowski C (2008) Antioxidant effectiveness of phenolic apple juice extracts and their gut fermentation products in the human colon carcinoma cell line caco-2. J Agric Food Chem 56:6310-6317
11. Napolitano A, Cascone A, Graziani G, Ferracane R, Scalfi L, Di Vaio C, Ritieni A, Fogliano V (2004) Influence of variety and storage on the polyphenol composition of apple flesh. J Agric Food Chem 52:6526-6531
12. Wojdylo A, Oszmianski J, Laskowski P (2008) Polyphenolic compounds and antioxidant activity of new and old apple varieties. J Agric Food Chem 56:6520-6530
13. Lee KW, Kim YJ, Kim DO, Lee HJ, Lee CY (2003) Major phenolics in apple and their contribution to the total antioxidant capacity. J Agric Food Chem 51:6516-6520
14. Ehrenkranz JR, Lewis NG, Kahn CR, Roth J (2005) Phlorizin: a review. Diabetes/Metab Res Rev 21:31-38
15. Pajor AM, Randolph KM, Kerner SA, Smith CD (2008) Inhibitor binding in the human renal low-and high-affinity Na?/glucose cotransporters. J Pharmacol Exp Ther 324:985-991
16. Tyagi NK, Kumar A, Goyal P, Pandey D, Siess W, Kinne RK (2007) D-Glucose recognition and phlorizin-binding sites in human sodium/D-glucose cotransporter 1 (hSGLT1): a tryptophan scanning study. Biochemistry 46:13616-13628
17. Liu IM, Chang CK, Juang SW, Kou DH, Tong YC, Cheng KC, Cheng JT (2008) Role of hyperglycaemia in the pathogenesis of hypotension observed in type-1 diabetic rats. Int J Exp Pathol 89:292-300
18. Zhao H, Yakar S, Gavrilova O, Sun H, Zhang Y, Kim H, Setser J, Jou W, LeRoith D (2004) Phloridzin improves hyperglycemia but not hepatic insulin resistance in a transgenic mouse model of type 2 diabetes. Diabetes 53:2901-2909
19. Takii H, Matsumoto K, Kometani T, Okada S, Fushiki T (1997) Lowering effect of phenolic glycosides on the rise in postprandial glucose in mice. Biosci Biotechnol Biochem 61:1531-1535
20. Oku A, Ueta K, Arakawa K, Ishihara T, Nawano M, Kuronuma Y, Matsumoto M, Saito A, Tsujihara K, Anai M, Asano T, Kanai Y, Endou H (1999) T-1095, an inhibitor of renal Na?-glucose cotransporters, may provide a novel approach to treating diabetes. Diabetes 48:1794-1800
21. Verges B (2009) Lipid disorders in type 1 diabetes. Diabetes Metab 35:353-360
22. Gosavi A, Flaker G, Gardner D (2006) Lipid management reduces cardiovascular complications in individuals with diabetes and prediabetes. Prev Cardiol 9:102-107
23. Park Byung Hyun, Lee Yung, Walton Marlei, Duplomb Laurence, Roger H (2004) Demonstration of reverse fatty acid transport from rat cardiomyocytes. J Lipid Res 45:1992-1999
24. Marshall JJ, Lauda CM (1975) Purification and properties of phaseolamin, an inhibitor of alpha-amylase, from the kidney bean, Phaseolus vulgaris. J Biol Chem 250:8030-8037
25. Tormo MA, Gil-Exojo I, Romero de Tejada A, Campillo JE (2004) Hypoglycaemic and anorexigenic activities of an a-amylase inhibitor from white kidney beans (Phaseolus vulgaris) in Wistar rats. Br J Nutr 92:785-790
26. Deeg R, Ziegenhorn J (1983) Kinetic enzymic method for automated determination of total cholesterol in serum. Clin Chem 29:1798-1802
27. Cole TG, Klotzsch SG, McNamara J (1997) Measurement of triglyceride concentration. In: Rifai N, Warnick GR, Dominiczack MH (eds) Handbook of lipoprotein testing. AACC Press, Washington, pp 115-126
28. Wiebe DA, Warnick GR (1997) Measurement of high-density lipoprotein cholesterol. In: Rifai N, Warnick GR, Dominiczack MH (eds) Handbook of lipoprotein testing. AACC Press, Washington, pp 127-144
29. Bachorik PS (1997) Measurement of low-density lipoprotein cholesterol. In: Rifai N, Warnick GR, Dominiczack MH (eds) Handbook of lipoprotein testing. AACC Press, Washington, pp 145-160
30. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
31. Navas PB (2009) Chemical composition of the virgin oil obtained by mechanical pressing form several grape seed varieties (Vitis vinifera L.) with emphasis on minor constituents. Arch Latinoam Nutr 59:214-219 (in Spanish)
32. Tangolar SG, Ozogul Y, Tangolar S, Torun A (2007) Evaluation of fatty acid profiles and mineral content of grape seed oil of some grape genotypes. Int J Food Sci Nutr 60:1-8
33. Alberton EH, Damazio RG, Cazarolli LH, Chiaradia LD, Leal PC, Nunes RJ, Yunes RA, Silva FR (2008) Influence of chalcone analogues on serum glucose levels in hyperglycemic rats. Chem Biol Interact 171:355-362
34. Najafian M, Ebrahim-Habibi A, Hezareh N, Yaghmaei P, Parivar K, Larijani B (2010) Trans-chalcone: a novel small molecule inhibitor of mammalian alpha-amylase. Mol Biol Rep. doi: 10.1007/s11033-010-0271-3
35. Lo Piparo E, Scheib H, Frei N, Williamson G, Grigorov M, Chou CJ (2008) Flavonoids for controlling starch digestion: structural requirements for inhibiting human a-amylase. J Med Chem 51:3555-3561
36. Beisswenger P, Heine RJ, Leiter LA, Moses A, Tuomilehto J (2004) Prandial glucose regulation in the glucose triad: emerging evidence and insights. Endocrine 25:195-202
37. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (2004) Acarbose for the prevention of type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data. Diabetologia 47:969-975
38. Yamagishi S, Nakamura K, Takeuchi M (2005) Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome. Med Hypotheses 65:152-154
39. Rosak C, Mertes G (2009) Effects of acarbose on proinsulin and insulin secretion and their potential significance for the intermediary metabolism and cardiovascular system. Curr Diabetes Rev 5:157-164
40. Casaschi A, Maiyoh GK, Rubio BK, Li RW, Adeli K, Theriault AG (2004) The chalcone xanthohumol inhibits triglyceride and apolipoprotein B secretion in HepG2 cells. J Nutr 134:1340-1346
41. Ogawa H, Ohno M, Baba K (2005) Hypotensive and lipid regulatory actions of 4-hydroxyderricin, a chalcone from Angelica keiskei, in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 32:19-23